deltatrials
Completed EARLY_PHASE1 INTERVENTIONAL 6-arm NCT00863265

Phytosterols, Ezetimibe, and Cholesterol Metabolism (Phyteaux-III)

Regulation of Cholesterol Absorption: LDL Cholesterol Response to a Combination of Phytosterols and Ezetimibe (Phyto-3)

Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Conditions Coronary Heart Disease Hypercholesterolemia
Interventions Ezetimibe Phytosterols + ezetimibe Placebo
Updated 9 times since 2017 Last updated: May 29, 2018 Started: Jun 30, 2009 Primary completion: Oct 31, 2009 Completion: Feb 28, 2010
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This EARLY_PHASE1 trial investigates Coronary Heart Disease and Hypercholesterolemia and is currently completed. National Heart, Lung, and Blood Institute (NHLBI) leads this study, which shows 9 recorded versions since 2009 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotCompleted~Feb 2017 – ~Jun 2018 · 16 months · monthly snapshotCompleted~Jun 2018 – ~Jul 2018 · 30 days · monthly snapshotCompleted~Jul 2018 – ~Jan 2021 · 30 months · monthly snapshotCompleted~Jan 2021 – ~Dec 2022 · 23 months · monthly snapshotCompleted~Dec 2022 – ~Jan 2023 · 31 days · monthly snapshotCompleted~Jan 2023 – ~Jul 2024 · 18 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

9 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed EARLY_PHASE1

  2. Jul 2024 — Sep 2024 [monthly]

    Completed EARLY_PHASE1

  3. Jan 2023 — Jul 2024 [monthly]

    Completed EARLY_PHASE1

  4. Dec 2022 — Jan 2023 [monthly]

    Completed EARLY_PHASE1

  5. Jan 2021 — Dec 2022 [monthly]

    Completed EARLY_PHASE1

▶ Show 4 earlier versions

  1. Jul 2018 — Jan 2021 [monthly]

    Completed EARLY_PHASE1

    Phase: NA → EARLY_PHASE1

  2. Jun 2018 — Jul 2018 [monthly]

    Completed NA

  3. Feb 2017 — Jun 2018 [monthly]

    Completed NA

  4. Jan 2017 — Feb 2017 [monthly]

    Completed NA

    First recorded

Jun 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • National Heart, Lung, and Blood Institute (NHLBI)
  • Utah State University
  • Washington University School of Medicine
Data source: Washington University School of Medicine

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations